A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy

Oncogene
Y WatanabeT Fujiwara

Abstract

Malignant pleural mesothelioma (MPM) is a highly aggressive tumor that is related to asbestos exposure. MPM is characterized by rapid and diffuse local growth in the thoracic cavity, and it has a poor prognosis because it is often refractory to conventional therapy. Although MPM is an extraordinarily challenging disease to treat, locoregional virotherapy may be useful against this aggressive disease because of the accessibility by intrapleural virus delivery. In this study, we show that telomerase-specific, replication-selective adenovirus OBP-301 can efficiently infect and kill human mesothelioma cells by viral replication. Intrathoracic administration of virus significantly reduced the number and size of human mesothelioma tumors intrathoracically implanted into nu/nu mice. A high-definition, fluorescence optical imaging system with an ultra-thin, flexible fibered microprobe clearly detected intracellular replication of green fluorescent protein-expressing oncolytic virus in intrathoracically established mesothelioma tumors. As the extracellular matrix (ECM) may contribute to the physiological resistance of a solid tumor by preventing the penetration of therapeutic agents (including oncolytic viruses), we also examined whethe...Continue Reading

References

Aug 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P RuffieA Figueredo
Mar 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A S AlbertsC A Van der Merwe
Dec 1, 1982·The Western Journal of Medicine·W N Rom, J E Lockey
Jun 1, 1982·Annals of Internal Medicine·A P ChahinianE M Mandel
Feb 1, 1997·American Journal of Epidemiology·B Price
Jan 23, 1998·Chest·C W RyanN J Vogelzang
Apr 20, 2000·Journal of the National Cancer Institute·C T YangD M Jablons
Jan 22, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Takeshi KawashimaToshiyoshi Fujiwara
Oct 26, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daniel H StermanSteven M Albelda
Dec 20, 2005·American Journal of Industrial Medicine·Takehiko MurayamaNorio Kurumatani
Oct 3, 2006·Nature Medicine·Hiroyuki KishimotoToshiyoshi Fujiwara
Oct 19, 2006·Journal of the National Cancer Institute·Joo-Hang KimChae-Ok Yun
Mar 7, 2007·British Journal of Pharmacology·E A McKenzie
Jul 27, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jin ChengJohn G Hay
Aug 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daniel H StermanMichelle Kanther
Mar 15, 2008·International Journal of Cancer. Journal International Du Cancer·Masayoshi HiokiToshiyoshi Fujiwara
Aug 27, 2009·Proceedings of the National Academy of Sciences of the United States of America·Hiroyuki KishimotoRobert M Hoffman

❮ Previous
Next ❯

Citations

Feb 9, 2013·Cancer Gene Therapy·M TagawaK Hiroshima
Mar 30, 2011·Human Gene Therapy·Elspeth SmithBrian D Lichty
Nov 5, 2010·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Fuminori Sakurai, Hiroyuki Mizuguchi
Jul 14, 2012·Expert Opinion on Biological Therapy·Donavon C Hiss, Burtram C Fielding
Dec 29, 2015·Molecular Therapy : the Journal of the American Society of Gene Therapy·Alison TedcastleKerry D Fisher
Apr 26, 2011·Journal of Process Control·Rutao LuoRyan Zurakowski
Mar 14, 2013·BioMed Research International·Yuji TadaMasatoshi Tagawa
Sep 21, 2017·Pathogens·Neel ThakkarDeepak Shukla
Mar 2, 2013·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Fuminori SakuraiHiroyuki Mizuguchi
Jun 22, 2017·Statistical Methods in Medical Research·Thomas AsendorfTim Friede
Nov 9, 2010·Journal of Biopharmaceutical Statistics·Norbert BendaSue-Jane Wang
Jul 1, 2013·Therapeutic Innovation & Regulatory Science·Daniel Wachtlin, Meinhard Kieser
May 18, 2018·Statistical Methods in Medical Research·Tobias MützeTim Friede
May 22, 2019·Frontiers in Oncology·Alyce J MayfoshMark D Hulett
May 19, 2011·Multiple Sclerosis : Clinical and Laboratory Research·Richard NicholasTim Friede
Jun 14, 2016·Journal of Biopharmaceutical Statistics·Anja SanderMeinhard Kieser
Sep 13, 2012·Experimental and Therapeutic Medicine·Masashi KobayashiHiroshi Date
Sep 9, 2017·Frontiers in Oncology·Daniel F Pease, Robert A Kratzke
Nov 22, 2018·Japanese Journal of Clinical Oncology·Satoru TaguchiTomoki Todo
Mar 12, 2021·Thorax·Marie ShamseddinStefan John Marciniak

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.